Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
LIVE TV DownloadNews18 App
News18 English
News18 » Business
1-min read

Pfizer Gets Patent For Pneumonia Vaccine in India

The grant of the patent means that Indian pharmaceutical firms will not be able to make Prevenar 13 in the country.

PTI

Updated:August 22, 2017, 10:06 PM IST
facebookTwitterskypewhatsapp
Pfizer Gets Patent For Pneumonia Vaccine in India
Pharma giants Pfizer and GlaxoSmithKline to join hands in a new venture.
Loading...

New Delhi: Multinational drug major Pfizer Inc on Tuesday said it has been granted patent in India for its vaccine Prevenar 13, used for protection against pneumonia.

The development has, however, been decried by Medicines Sans Frontiers (MSF), an international medical humanitarian organisation saying granting patent on the vaccine could impact its availability.

The grant of the patent means that Indian pharmaceutical firms will not be able to make the vaccine.

"We are pleased to note that the validity of the Prevenar 13 patent has now been recognised by the Indian Patent Office," a Pfizer spokesperson said in a statement.

This vaccine was launched in India in 2010. In its multi-dose vial presentation, this vaccine has been included in the expansion of India's public immunisation program in select states under the GAVI funded platform, it added.

Criticising the grant of patent to Pfizer, MSF Asia Regional Coordinator Prince Mathew said: "It is unfair and unacceptable that almost a million children die each year from pneumonia, even though a life-saving vaccine is available."

Stating that the development would hit access to the vaccine, he said children everywhere have a right to be protected from pneumonia, but many governments cannot afford the prices set by Pfizer.

Pfizer, however, said it remained committed towards further enhancing access of this vaccine in India, both in the market as well as through partnership with the Government to expand introduction in the public program.

"Prevenar 13 provides the broadest serotype coverage of any pneumococcal conjugate vaccine available in the world on Tuesday," the company spokesperson said.

MSF said it had challenged Pfizer's "unmerited patent claims" in India, after the same patent was revoked by the European Patent Office (EPO) in 2016.

"The patent is also being legally challenged in South Korea and before the US Patent Trademark Appeal Board," MSF said.

Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow News18.com on Twitter, Instagram, Facebook, TikTok and on YouTube, and stay in the know with what's happening in the world around you – in real time.

Subscribe to Moneycontrol Pro and gain access to curated markets data, trading recommendations, equity analysis, investment ideas, insights from market gurus and much more. Get Moneycontrol PRO for 1 year at price of 3 months. Use code FREEDOM.

| Edited by: Bijaya Das
Read full article
Loading...
Next Story
Next Story

Also Watch

facebookTwitterskypewhatsapp
Most Active
Company Price Change %Gain
Yes Bank 65.40 -8.15
Maruti Suzuki 6,196.00 0.08
Indiabulls Hsg 483.55 -7.26
Tata Motors 112.40 -9.25
SBI 277.40 -2.22
Company Price Change %Gain
Maruti Suzuki 6,222.95 0.39
Yes Bank 65.40 -8.21
Indiabulls Hsg 475.00 -8.91
Tata Motors 112.30 -9.29
Abbott India 8,945.00 -0.59
Top Gainers
Company Price Change %Gain
Hero Motocorp 2,714.25 1.69
Infosys 799.45 0.85
Bajaj Auto 2,764.80 0.80
Eicher Motors 16,000.50 0.66
Maruti Suzuki 6,228.90 0.61
Company Price Change %Gain
Hero Motocorp 2,716.90 1.78
Maruti Suzuki 6,222.95 0.39
Infosys 798.85 0.75
HUL 1,854.00 0.70
Bajaj Auto 2,761.75 0.69
Top Losers
Company Price Change %Gain
Tata Motors 112.40 -9.25
Yes Bank 65.40 -8.15
Indiabulls Hsg 483.55 -7.26
Tata Steel 343.00 -4.26
BPCL 327.80 -4.22
Company Price Change %Gain
Tata Motors 112.30 -9.29
Yes Bank 65.40 -8.21
Tata Steel 343.05 -4.26
Coal India 188.50 -3.46
ONGC 121.15 -3.12

Live TV

Loading...
Countdown To Elections Results
To Assembly Elections 2018 Results